首页> 外文期刊>Hellenic Journal of Cardiology >Long-term clinical outcomes of optimal medical therapy vs. successful percutaneous coronary intervention for patients with coronary chronic total occlusions
【24h】

Long-term clinical outcomes of optimal medical therapy vs. successful percutaneous coronary intervention for patients with coronary chronic total occlusions

机译:冠状动脉慢性完全闭塞患者最佳药物治疗与成功经皮冠状动脉介入治疗的长期临床结果

获取原文
       

摘要

Objectives There are little data on the long-term clinical outcomes of optimal medical therapy (OMT) compared with successful percutaneous coronary intervention (PCI) in patients with chronic total occlusions (CTOs). Methods A total of 388 patients with ≥1 CTO were enrolled from January 2008 to December 2010. 62 patients were excluded, and 326 patients were divided into an OMT group (n?=?125) and PCI group (n?=?201) according to the initial treatment strategy. Propensity-score matching was also done to adjust for baseline characteristics. The primary outcome was major adverse cardiac event (MACE), included cardiac death, recurrent myocardial infarction, and repeated revascularization. Results After a mean follow-up of 47.2?±?20.0 months, there was no significant difference between the two groups with respect to the prevalence of MACE (successful PCI vs. OMT: 29.6% vs. 21.9%, unadjusted hazard ratio [HR] 1.47, 95% confidence interval [CI] 0.95–2.28, p=0.085). After multivariate analyses, there were significant differences in the prevalence of MACE (adjusted HR 1.76, 95% CI 1.09–2.28, p=0.02) and repeated revascularization (2.14; 1.18–3.90, 0.01). In the propensity score-matched population (80 pairs), there were no significant differences in the prevalence of MACE (adjusted HR 1.89, 95% CI 0.96–3.71, p=0.06) and cardiac death (1.30, 0.44–3.80, 0.63) between groups. Conclusion In the treatment of patients with CTOs, successful PCI did not reduce the long-term risk of MACE compared with OMT.
机译:目的对于慢性完全阻塞(CTO)患者,与成功的经皮冠状动脉介入治疗(PCI)相比,最佳药物治疗(OMT)的长期临床疗效数据很少。方法自2008年1月至2010年12月,共纳入388例CTO≥1的患者。排除62例,将326例分为OMT组(n = 125)和PCI组(n = 201)。根据初始治疗策略。倾向得分匹配也进行了调整以适应基线特征。主要预后为严重不良心脏事件(MACE),包括心脏死亡,反复发作的心肌梗塞和反复血运重建。结果在平均随访47.2±20.0个月后,两组之间的MACE发生率无显着差异(成功PCI与OMT:29.6%vs. 21.9%,未调整风险比[HR ] 1.47,95%置信区间[CI] 0.95-2.28,p = 0.085)。经过多变量分析后,MACE的发生率(校正后的HR 1.76,95%CI 1.09–2.28,p = 0.02)和重复血运重建有显着差异(2.14; 1.18–3.90,0.01)。在倾向得分匹配的人群(80对)中,MACE的患病率(校正后的HR 1.89,95%CI 0.96-3.71,p = 0.06)和心源性死亡(1.30、0.44-3.80、0.63)没有显着差异。组之间。结论在CTO患者的治疗中,与OMT相比,成功的PCI不能降低MACE的长期风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号